-
EP3805268
European procedure
Extract from the Register of European Patents
EP About this file: EP3805268
| EP3805268 - ANTIBODY THAT BINDS ERBB-2 AND ERBB-3 [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 01.11.2024 Database last updated on 26.04.2025 | |
| Former | Grant of patent is intended Status updated on 11.07.2024 | ||
| Former | Examination is in progress Status updated on 26.05.2023 | ||
| Former | Request for examination was made Status updated on 12.03.2021 | Most recent event Tooltip | 06.12.2024 | Change - divisional application(s) | published on 08.01.2025 [2025/02] | Applicant(s) | For all designated states Merus N.V. Uppsalalaan 17 3e en 4e verdieping 3584 CT Utrecht / NL | [2023/06] |
| Former [2021/15] | For all designated states Merus N.V. Yalelaan 62 3584 CM Utrecht / NL | Inventor(s) | 01 /
GEUIJEN, Cecilia Anna Wilhelmina 3584 CT Utrecht / NL | 02 /
DE KRUIF, Cornelis Adriaan 3584 CT Utrecht / NL | 03 /
THROSBY, Mark 3584 CT Utrecht / NL | 04 /
LOGTENBERG, Ton 3584 CT Utrecht / NL | 05 /
BAKKER, Alexander Berthold Hendrik 3584 CT Utrecht / NL | [2023/06] |
| Former [2021/15] | 01 /
GEUIJEN, Cecilia Anna Wilhelmina c/o Yalelaan 62 3584 CM Utrecht / NL | ||
| 02 /
DE KRUIF, Cornelis Adriaan c/o Yalelaan 62 3584 CM Utrecht / NL | |||
| 03 /
THROSBY, Mark c/o Yalelaan 62 3584 CM Utrecht / NL | |||
| 04 /
LOGTENBERG, Ton c/o Yalelaan 62 3584 CM Utrecht / NL | |||
| 05 /
BAKKER, Alexander Berthold Hendrik c/o Yalelaan 62 3584 CM Utrecht / NL | Representative(s) | V.O. P.O. Box 87930 2508 DH Den Haag / NL | [2021/15] | Application number, filing date | 20191815.8 | 27.02.2015 | [2021/15] | Priority number, date | EP20140157360 | 28.02.2014 Original published format: EP 14157360 | EP20140167066 | 05.05.2014 Original published format: EP 14167066 | [2021/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3805268 | Date: | 14.04.2021 | Language: | EN | [2021/15] | Type: | B1 Patent specification | No.: | EP3805268 | Date: | 04.12.2024 | Language: | EN | [2024/49] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.03.2021 | Classification | IPC: | C07K16/32, A61P9/04, A61P35/00, A61P35/04, A61P43/00 | [2021/15] | CPC: |
C07K16/32 (EP,CN,IL,KR,US);
A61K31/185 (IL,US);
A61K31/337 (IL,US);
A61K31/436 (IL,US);
A61K31/4375 (IL,US);
A61K31/4439 (IL,US);
A61K31/519 (IL,US);
A61K39/3955 (IL);
A61K39/39558 (IL,US);
A61P35/00 (EP,IL,KR);
A61P35/04 (EP,IL);
A61P43/00 (EP,IL);
A61P9/04 (EP,IL);
C07K16/30 (IL,US);
A61K2039/505 (IL,KR,US);
C07K2317/24 (IL,US);
C07K2317/31 (EP,CN,IL,KR,US);
C07K2317/526 (IL,US);
C07K2317/55 (EP,CN,IL,US);
C07K2317/565 (EP,CN,IL,KR,US);
C07K2317/732 (EP,CN,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/15] | Extension states | BA | 19.08.2020 | ME | 19.08.2020 | Title | German: | ERBB-2- UND ERBB-3-BINDENDER ANTIKÖRPER | [2021/15] | English: | ANTIBODY THAT BINDS ERBB-2 AND ERBB-3 | [2021/15] | French: | ANTICORPS LIANT ERBB-2 ET ERBB-3 | [2021/15] | Examination procedure | 19.08.2020 | Examination requested [2021/15] | 14.10.2021 | Amendment by applicant (claims and/or description) | 30.05.2023 | Despatch of a communication from the examining division (Time limit: M04) | 09.10.2023 | Reply to a communication from the examining division | 19.12.2023 | Despatch of a communication from the examining division (Time limit: M04) | 19.04.2024 | Reply to a communication from the examining division | 12.07.2024 | Communication of intention to grant the patent | 28.10.2024 | Fee for grant paid | 28.10.2024 | Fee for publishing/printing paid | 28.10.2024 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP15708907.9 / EP3110849 | Divisional application(s) | EP24216946.4 | Fees paid | Renewal fee | 19.08.2020 | Renewal fee patent year 03 | 19.08.2020 | Renewal fee patent year 04 | 19.08.2020 | Renewal fee patent year 05 | 19.08.2020 | Renewal fee patent year 06 | 19.01.2021 | Renewal fee patent year 07 | 18.01.2022 | Renewal fee patent year 08 | 17.01.2023 | Renewal fee patent year 09 | 23.01.2024 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2012125864 (MERRIMACK PHARMACEUTICALS INC [US], et al); | [XP]WO2014060365 (UNIVERSITÄT ZÜRICH PROREKTORAT MNW [CH]); | by applicant | US2003078385 | WO2004009618 | US2006212956 | WO2008027236 | WO2008100624 | WO2009157771 | US7705103 | WO2010108127 | US2011077163 | US2012107306 | US8349574 | US2013071859 | WO2013134686 | WO2013157954 | US19350616359 | US20080340436 | WO2013NL50294 | WO2014US33208 |